Judge Upholds Claims 1 And 14 Of United Therapeutics' '327 Patent, Rules Liquidia Infringes; Final Judgment Due Within One Week

A judge has upheld claims 1 and 14 of United Therapeutics' '327 patent, ruling that Liquidia infringes on these claims. A final judgment regarding the case is expected within one week. This ruling could have significant implications for United Therapeutics' market position and patent protection.